These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 21837697)

  • 1. Clinical significance of TRAIL and TRAIL receptors in patients with head and neck cancer.
    Yoldas B; Ozer C; Ozen O; Canpolat T; Dogan I; Griffith TS; Sanlioglu S; Ozluoglu LN
    Head Neck; 2011 Sep; 33(9):1278-84. PubMed ID: 21837697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The expression of tumor necrosis factor related apoptosis induce ligand in human laryngeal squamous cell carcinoma].
    Yao H; Ji W; Guan C; Liu B
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2006 Dec; 20(24):1105-8. PubMed ID: 17357513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TRAIL and TRAIL receptors in patients with laryngeal cancer.
    Erkul E; Kucukodaci Z; Pinar D; Gungor A; Alparslan Babayigit M; Kurt O; Cincik H
    Head Neck; 2016 Apr; 38 Suppl 1():E535-41. PubMed ID: 25810124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repression of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) but not its receptors during oral cancer progression.
    Vigneswaran N; Baucum DC; Wu J; Lou Y; Bouquot J; Muller S; Zacharias W
    BMC Cancer; 2007 Jun; 7():108. PubMed ID: 17592646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TRAIL death receptor-4 expression positively correlates with the tumor grade in breast cancer patients with invasive ductal carcinoma.
    Sanlioglu AD; Korcum AF; Pestereli E; Erdogan G; Karaveli S; Savas B; Griffith TS; Sanlioglu S
    Int J Radiat Oncol Biol Phys; 2007 Nov; 69(3):716-23. PubMed ID: 17512128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High levels of endogenous tumor necrosis factor-related apoptosis-inducing ligand expression correlate with increased cell death in human pancreas.
    Sanlioglu AD; Dirice E; Elpek O; Korcum AF; Balci MK; Omer A; Griffith TS; Sanlioglu S
    Pancreas; 2008 May; 36(4):385-93. PubMed ID: 18437085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and TRAIL receptors in renal cell cancer.
    Macher-Goeppinger S; Aulmann S; Tagscherer KE; Wagener N; Haferkamp A; Penzel R; Brauckhoff A; Hohenfellner M; Sykora J; Walczak H; Teh BT; Autschbach F; Herpel E; Schirmacher P; Roth W
    Clin Cancer Res; 2009 Jan; 15(2):650-9. PubMed ID: 19147771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of androgen ablation therapy in TRAIL death ligand and its receptors expression in advanced prostate cancer.
    Koksal IT; Sanlioglu AD; Kutlu O; Sanlioglu S
    Urol Int; 2010; 84(4):445-51. PubMed ID: 20339295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced susceptibility to tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in oral squamous cell carcinoma cells treated with phosphatidylinositol 3-kinase inhibitors.
    Uchida M; Iwase M; Takaoka S; Yoshiba S; Kondo G; Watanabe H; Ohashi M; Nagumo M; Shintani S
    Int J Oncol; 2007 May; 30(5):1163-71. PubMed ID: 17390018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Synergistic effects and mechanisms of combined tumor necrosis factor-related apoptosis-inducing ligand and chemotherapeutic drugs or radiotherapy in killing laryngeal squamous carcinoma cells in vitro].
    Zhang M; Zhou L
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2009 Jul; 44(7):565-70. PubMed ID: 19957654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of TNF-related apoptosis-inducing ligand (TRAIL) and its receptors in gastric carcinoma and tumor-infiltrating lymphocytes: a possible mechanism of immune evasion of the tumor.
    Koyama S; Koike N; Adachi S
    J Cancer Res Clin Oncol; 2002 Feb; 128(2):73-9. PubMed ID: 11862476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A study of TRAIL receptors in squamous cell carcinoma of the head and neck.
    Teng MS; Brandwein-Gensler MS; Teixeira MS; Martignetti JA; Duffey DC
    Arch Otolaryngol Head Neck Surg; 2005 May; 131(5):407-12. PubMed ID: 15897419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nuclear and cytoplasmic death receptor 5 as prognostic factors in patients with non-small cell lung cancer treated with chemotherapy.
    Leithner K; Stacher E; Wurm R; Ploner F; Quehenberger F; Wohlkoenig C; Bálint Z; Polachova J; Olschewski A; Samonigg H; Popper HH; Olschewski H
    Lung Cancer; 2009 Jul; 65(1):98-104. PubMed ID: 19081160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TNF-alpha-related apoptosis-inducing ligand decoy receptor DcR2 is targeted by androgen action in the rat ventral prostate.
    Vindrieux D; Réveiller M; Florin A; Blanchard C; Ruffion A; Devonec M; Benahmed M; Grataroli R
    J Cell Physiol; 2006 Mar; 206(3):709-17. PubMed ID: 16245307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TNF-related apoptosis-inducing ligand: signalling of a 'smart' molecule.
    Manzo F; Nebbioso A; Miceli M; Conte M; De Bellis F; Carafa V; Franci G; Tambaro FP; Altucci L
    Int J Biochem Cell Biol; 2009 Mar; 41(3):460-6. PubMed ID: 18243765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thyroid carcinoma cells are resistant to FAS-mediated apoptosis but sensitive to tumor necrosis factor-related apoptosis-inducing ligand.
    Mitsiades N; Poulaki V; Tseleni-Balafouta S; Koutras DA; Stamenkovic I
    Cancer Res; 2000 Aug; 60(15):4122-9. PubMed ID: 10945619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TRAIL receptor signaling and therapeutics.
    Abdulghani J; El-Deiry WS
    Expert Opin Ther Targets; 2010 Oct; 14(10):1091-108. PubMed ID: 20819019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Apoptosis inducing effect by TRAIL on human laryngeal squamous carcinoma Hep-2 cells].
    Yao H; Xiao H; Wang C; Liu M; Jin D
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2011 Feb; 25(3):127-9. PubMed ID: 21553526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of new TRAIL mutants DR5-A and DR5-B with improved selectivity to death receptor 5.
    Gasparian ME; Chernyak BV; Dolgikh DA; Yagolovich AV; Popova EN; Sycheva AM; Moshkovskii SA; Kirpichnikov MP
    Apoptosis; 2009 Jun; 14(6):778-87. PubMed ID: 19412666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased expression of TRAIL and its receptors on peripheral T-cells in type 1 diabetic patients.
    Salehi E; Vodjgani M; Massoud A; Keyhani A; Rajab A; Shafaghi B; Gheflati Z; Aboufazeli T
    Iran J Immunol; 2007 Dec; 4(4):197-205. PubMed ID: 18057577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.